In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 8-K | 8-K | 10-Q | 10-Q | 10-K | 8-K |
Interest income: |
Interest income on loans | 52.1 | 45.9 | 42.5 | 38.5 | 34.3 | 35.0 | 31.0 | 29.6 |
Interest income on investments | 4.4 | 4.3 | 4.2 | 3.8 | 3.2 | 2.3 | | |
Interest income on repurchase agreements | 0.0 | 0.0 | | | 0.7 | 0.3 | | |
| 56.6 | 50.2 | 46.7 | 43.0 | 38.2 | 37.6 | 32.7 | 30.7 |
Interest expense: |
Interest on deposits | 17.9 | 12.0 | | | 2.0 | 2.3 | 2.5 | 2.9 |
Interest on borrowings | | | 0.4 | | | | | 0.1 |
| 20.1 | 14.2 | 8.2 | 3.6 | 2.8 | 3.2 | 3.3 | 3.7 |
Net interest income | 36.4 | 36.0 | 38.6 | 39.4 | 35.4 | 34.4 | 29.4 | 27.0 |
Provision for loan losses | | | | | | | | 0.4 |
Net interest income after provision for loan losses | 36.4 | 36.0 | 38.6 | 39.4 | 35.4 | 34.4 | 29.4 | 26.6 |
Other non-interest income | 5.2 | 4.3 | 6.7 | 6.0 | 5.2 | 5.8 | 5.7 | 5.5 |
Total non-interest income | 5.2 | 4.3 | 6.7 | 6.0 | 5.2 | 5.8 | 5.7 | 5.5 |
Non-interest expenses | 35.5 | 26.1 | 25.5 | 24.7 | 23.9 | 25.7 | 34.1 | 20.0 |
Pre-tax income before non-recurring items | 10.0 | 14.0 | 19.3 | 19.1 | 15.0 | 13.9 | 3.7 | 12.1 |
Non-recurring items | 5.0 | 0.2 | | | | | 3.1 | |
Pre-tax income | 5.0 | 13.8 | 19.3 | 19.1 | 15.0 | 13.9 | 0.6 | 12.1 |
Income taxes | 0.1 | 2.6 | 3.6 | 3.6 | 2.8 | 2.6 | 0.0 | 2.3 |
Tax rate | 2.9% | 18.7% | 18.5% | 19.0% | 18.4% | 18.4% | | 18.8% |
Net income | 4.8 | 11.2 | 15.7 | 15.5 | 12.3 | 11.4 | 29.3 | 9.8 |
Net margin | 11.6% | 27.8% | 34.7% | 34.1% | 30.1% | 28.3% | 78.0% | 30.5% |
|
Basic EPS | $0.30 | $0.71 | $0.99 | $0.97 | $0.77 | $0.71 | $2.71 | $0.86 |
Diluted EPS | $0.30 | $0.70 | $0.99 | $0.97 | $0.77 | $0.71 | $2.71 | $0.86 |
|
Shares outstanding (basic) | 16.2 | 15.9 | 15.9 | 16.0 | 15.9 | 16.0 | 10.8 | 11.4 |
Shares outstanding (diluted) | 16.3 | 15.9 | 15.9 | 16.0 | 15.9 | 16.0 | 10.8 | 11.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |